The RNA Component of Human Telomerase
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Eukaryotic chromosomes are capped with repetitive telomere sequences that protect the ends from damage and rearrangements. Telomere repeats are synthesized by telomerase, a ribonucleic acid (RNA)-protein complex. Here, the cloning of the RNA component of human telomerase, termed hTR, is described. The template region of hTR encompasses 11 nucleotides (5′-CUAACCCUAAC) complementary to the human telomere sequence (TTAGGG) n . Germline tissues and tumor cell lines expressed more hTR than normal somatic cells and tissues, which have no detectable telomerase activity. Human cell lines that expressed hTR mutated in the template region generated the predicted mutant telomerase activity. HeLa cells transfected with an antisense hTR lost telomeric DNA and began to die after 23 to 26 doublings. Thus, human telomerase is a critical enzyme for the long-term proliferation of immortal tumor cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Key components of telomerase are telomerase reverse transcriptase (TERT) (88) and telomerase RNA (89).”
From The Discovery of Reverse Transcriptase (2016) · cites this paper as [89]
In the citing paper
“expression of antisense RNA complementary to the human telomerase RNA component (hTR) caused decreased proliferation of HeLa cells after 23 to 26 doublings (24).”
From Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death (1999) · cites this paper as [24]
In the citing paper
“The shortening of telomeres occurs with each cell division, ultimately causing cells to reach their Hayflick limit, whereby growth stops after approximately 60 times population doubling [2,3,4,5].”
From Cell Immortality: In Vitro Effective Techniques to Achieve and Investigate Its Applications and Challenges (2024) · cites this paper as [5]
In the citing paper
“When telomeres become too short and cannot function naturally, cellular senescence in the M1 phase (a cellular growth arrest, also called the M1 stage) occurs [5,6,7].”
From Cell Immortality: In Vitro Effective Techniques to Achieve and Investigate Its Applications and Challenges (2024) · cites this paper as [5]
In the citing paper
“In human cells, the enzyme comprises a high molecular weight complex with a template-containing RNA subunit (Feng et al., 1995) and protein components including the catalytic subunit human telomerase reverse transcriptase, hTERT (Harrington et al., 1997;Meyerson et al., 1997;Nakamura et al., 1997).”
From A highly selective telomerase inhibitor limiting human cancer cell proliferation (2001) · cites this paper as Feng et al., 1995
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091
Self-citationTelomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
Self-citationTight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943
Identification of a specific telomere terminal transferase activity in tetrahymena extracts
Greider, C. W., & Blackburn, E. H. (1985) · Cell · doi:10.1016/0092-8674(85)90170-9 · Cited by 3,400
Self-citationTelomere length predicts replicative capacity of human fibroblasts.
Allsopp, R. C., Vaziri, H., Patterson, C., Goldstein, S., Younglai, E. V., Futcher, A. B., Greider, C. W., & Harley, C. B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10114 · Cited by 2,200
Self-citationCounter, C. M., Avilion, A. A., LeFeuvre, C. E., Stewart, N. G., Greider, C. W., Harley, C. B., & Bacchetti, S. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05245.x · Cited by 2,096
Self-citationOlovnikov (1973) · doi:10.1016/0022-5193(73)90198-7 · Cited by 1,847
Telomere reduction in human colorectal carcinoma and with ageing
Hastie, N. D., Dempster, M., Dunlop, M. G., Thompson, A. M., Green, D. K., & Allshire, R. C. (1990) · Nature · doi:10.1038/346866a0 · Cited by 1,650
A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis
Greider, C. W., & Blackburn, E. H. (1989) · Nature · doi:10.1038/337331a0 · Cited by 1,643
Self-citation
Research works printed but not linked: 7
- AUTEXIER, C, FUNCTIONAL RECONSTITUTION OF WILD-TYPE AND MUTANT TETRAHYMENA TELOMERASE, GENES & DEVELOPMENT 8: 563 (1994). · DOI
- AVILION A.A. THESIS STATE U NEW Y (1995).
- Broccoli, D., Proceedings of the National Academy of Sciences of the United States of America 92: 9082 (1995).
- CHADENEAU, C, ONCOGENE 11: 841 (1995).
- Hernandez, N., Transcriptional Regulation: 281 (1992).
- Muller, H. J., Collecting Net 13: 181 (1938).
- WATSON, J. D., NATURE-NEW BIOLOGY 239: 197 (1972).
Cited by
Items 601–700 of 1,004
Aging and Survival of Cutaneous Microvasculature
Chang, E., Yang, J., Nagavarapu, U., & Herron, G. S. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.01714.x · Cited by 70
Self-citationChalak, M., Hesaraki, M., Mirbahari, S. N., Yeganeh, M., Abdi, S., Rajabi, S., & Hemmatzadeh, F. (2024) · Life · doi:10.3390/life14030417 · Cited by 66
“When telomeres become too short and cannot function naturally, cellular senescence in the M1 phase (a cellular growth arrest, also called the M1 stage) occurs [5–7].”
BackgroundInfluentialProtein encoded in human telomerase RNA is involved in cell protective pathways
Rubtsova, M. P., Нарайкина, Ю. В., Vasilkova, D., Meerson, M., Zvereva, M. I., Prassolov, V., Лазарев, В. Н., Manuvera, V. A., Kovalchuk, S. I., Anikanov, N. A., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky705 · Cited by 66
“The mature form of hTERC contains 451 nt, although longer transcripts have been determined by reverse transcription followed by polymerase chain reaction (RT-PCR) (9) and rapid amplification of cDNA 3’-end (3′-RACE) (12) approaches (Figure 1A).”
BackgroundMethodZaki, M. B., Abd‐Elmawla, M. A., Elimam, H., El-Din, H. G., Fawzy, A., Abulsoud, A. I., & Rizk, S. M. (2023) · Non-coding RNA Research · doi:10.1016/j.ncrna.2023.03.004 · Cited by 65
Chen, Z., Koeneman, K. S., & Corey, D. R. (2003) · PubMed · Cited by 72
Cip/Kip cyclin-dependent kinase inhibitors: brakes of the cell cycle engine during development
Nakayama, K.-I., & Nakayama, K. (1999) · BioEssays · doi:10.1002/(sici)1521-1878(199812)20:12<1020::aid-bies8>3.0.co;2-d · Cited by 205
Telomerase in (pre)neoplastic cervical disease
Wisman, G. B. A., Jong, S. D., Meersma, G. J., Helder, M. N., Hollema, H., de Vries, E. G., Keith, W. N., & van der Zee, A. G. (2000) · Human Pathology · doi:10.1053/hupa.2000.19299 · Cited by 71
Zhuang, Y., Shang, C., Lou, X., & Xia, F. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.6b04696 · Cited by 65
Zhang, X., Dong, N., Zhang, H., You, J., Wang, H., & Ye, L. (2005) · Journal of Laboratory and Clinical Medicine · doi:10.1016/j.lab.2004.11.018 · Cited by 69
Patrick, M. S., & Weng, N. (2019) · Cellular Immunology · doi:10.1016/j.cellimm.2019.103989 · Cited by 71
Huang, H., Chiou, J.-F., Fong, Y., Hou, C.-C., Lu, Y.-C., Wang, J.-Y., Shih, J.-W., Pan, Y.-R., & Lin, J. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm020492l · Cited by 66
TELOMERASE IN UROLOGICAL MALIGNANCY
Orlando, C., Gelmini, S., Selli, C., & Pazzagli, M. (2001) · The Journal of Urology · doi:10.1016/s0022-5347(05)66040-5 · Cited by 68
Modeling chromosomal instability and epithelial carcinogenesis in the telomerase-deficient mouse
Chang, S. S., Khoo, C., & DePinho, R. A. (2001) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0374 · Cited by 71
Telomerase activity and expression of its RNA component in cervical lesions
Yashima, K., Ashfaq, R., Nowak, J. A., von Gruenigen, V., Milchgrub, S., Rathi, A., Albores‐Saavedra, J., Shay, J. W., & Gazdar, A. F. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980401)82:7<1396::aid-cncr25>3.0.co;2-0 · Cited by 64
Telomeres and telomerase as targets for cancer therapy
Zimmermann, S., & Martens, U. M. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-6481-8 · Cited by 71
Telomere and telomerase in oncology
Mu, J., & Li Xin, W. E. I. (2002) · Cell Research · doi:10.1038/sj.cr.7290104 · Cited by 70
“The sequence is complementary to one entire telomeric hexanucleotide and a fraction of adjacent repeats and so constitutes the template region of the molecule [6].”
BackgroundNutrition and lifestyle in healthy aging: the telomerase challenge
Boccardi, V., Paolisso, G., & Mecocci, P. (2016) · Aging · doi:10.18632/aging.100886 · Cited by 60
“In contrast to stem cells which constitutively express low levels of telomerase, normal somatic human cells repress its expression immediately after birth [24-27].”
BackgroundZhang, C., Guo, X., Jiang, G., Zhang, L., Yang, Y., Shen, F., Wu, M., & Wei, L. (2008) · International Journal of Cancer · doi:10.1002/ijc.23650 · Cited by 67
“The rate of telomere DNA shortening is regulated by telomerase expression and activity.(10) A num-”
BackgroundGenistein induces growth arrest and suppresses telomerase activity in brain tumor cells
Khaw, A. K., Yong, J. W. Y., Kalthur, G., & Hande, M. P. (2012) · Genes Chromosomes and Cancer · doi:10.1002/gcc.21979 · Cited by 68
“Telomerase consists of a RNA template (TR) that is complementary to telomere sequence (Greider and Blackburn, 1987; Feng et al., 1995), a catalytic subunit of reverse transcriptase (TERT) (Nakamura et al.”
BackgroundVaziri, H., Chapman, K., Guigova, A., Teichroeb, J., Lacher, M., Sternberg, H., Singec, I., Briggs, L., Wheeler, J., Sampathkumar, J., et al. (2010) · Regenerative Medicine · doi:10.2217/rme.10.21 · Cited by 61
Self-citationLi, P., Wu, M., Wang, J., Sui, Y., Liu, S., & Shi, D. (2015) · Redox Biology · doi:10.1016/j.redox.2015.12.001 · Cited by 65
“They are synthesized by telomerase consisting of a reverse transcriptase catalytic subunit (TERT) and an RNA template subunit (TERC) [3,4].”
A Brief History of the Mortality and Immortality of Cultured Cells.
Hayflick, L. (1998) · The Keio Journal of Medicine · doi:10.2302/kjm.47.174 · Cited by 74
Telomeres, replicative senescence and human ageing
Kipling, D. (2001) · Maturitas · doi:10.1016/s0378-5122(00)00189-4 · Cited by 76
“The latter, called hTERC, contains a short region used to template the synthesis of (TTAGGG)n repeats [49].”
BackgroundChange in Telomerase Activity of Rat Organs during Growth and Aging
Yamaguchi, Y., Nozawa, K., Savoysky, E., Hayakawa, N., Nimura, Y., & Yoshida, S. (1998) · Experimental Cell Research · doi:10.1006/excr.1998.4102 · Cited by 63
Do telomerase antagonists represent a novel anti-cancer strategy?
Parkinson, E. K. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.1 · Cited by 62
Disney, M. D., Dwyer, B. G., & Childs‐Disney, J. L. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a034769 · Cited by 68
“Interestingly, telomerase is highly expressed in stem cells and cancer cells but has very low expression and activity in somatic cells (Feng et al. 1995).”
BackgroundPossible association between gastric cancer and bracken fern in Venezuela: An epidemiologic study
Alonso‐Amelot, M. E., & Avendaño, M. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(20010115)91:2 · Cited by 66
Telomere Length Homeostasis Responds to Changes in Intracellular dNTP Pools
Gupta, A., Sharma, S., Reichenbach, P., Marjavaara, L., Nilsson, A. K., Lingner, J., Chabes, A., Rothstein, R. J., & Chang, M. (2013) · Genetics · doi:10.1534/genetics.112.149120 · Cited by 65
Wei, C.-W., Lin, C.-C., Yu, Y.-L., Lin, P.-C., Lin, P.-C., Wu, M.-T., Chen, C.-J., Chang, W., Lin, S.-Z., Chen, Y.-L. S., et al. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.124 · Cited by 66
Telomerase is regulated by protein kinase C-ζ in human nasopharyngeal cancer cells
Yu, C.-C., Shi-Ching, L. O., & Wang, T. V. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3550459 · Cited by 66
Telomerase activity and telomere length as prognostic factors of adult T-cell leukemia
Kubuki, Y., Suzuki, M., Sasaki, H., Toyama, T., Yamashita, K., Maeda, K., Ido, A., Matsuoka, H., Okayama, A., Nakanishi, T., et al. (2004) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190400018349 · Cited by 62
Wen, J., Cong, Y.-S., & Bacchetti, S. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.7.1137 · Cited by 61
“Clone C3 was then infected with adenovirus vectors encoding hTER mutant 34 (AdU2-34) or 37 (Ad37) and cell extracts were assayed for the corresponding mutant telomerase activity (Fig. 4A) using specific primers ( 9 ,24).”
BackgroundMethodTaheri, M. N., Ghafouri‐Fard, S., Najafi, S., Kallenbach, J., Keramatfar, E., Roozbahani, G. A., Horestani, M. H., Hussen, B. M., & Baniahmad, A. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02678-9 · Cited by 66
“genome maintenance by stabilizing the telomere length through adding repetitive sequences (5′-TTA GGG n hexameric repeats in mammals) to telomeres during cell division [9].”
BackgroundPosttranscriptional manipulation of TERC reverses molecular hallmarks of telomere disease
Boyraz, B., Moon, D. H., Segal, M., Muosieyiri, M. Z., Aykanat, A., Tai, A. K., Cahan, P., & Agarwal, S. (2016) · Journal of Clinical Investigation · doi:10.1172/jci87547 · Cited by 58
MYC drives overexpression of telomerase RNA ( hTR / TERC ) in prostate cancer
Valle, J. A. B.-D., Zheng, Q., Esopi, D., Rubenstein, M., Hubbard, G. K., Moncaliano, M. C., Hruszkewycz, A. M., Vaghasia, A. M., Yegnasubramanian, S., Wheelan, S. J., et al. (2017) · The Journal of Pathology · doi:10.1002/path.4980 · Cited by 66
“Telomerase consists of at least two essential elements, a catalytic protein component (TERT) for adding telomeric DNA repeats onto chromosome ends and an RNA subunit (hTR or TERC) that serves as the template for telomere repeat addition [3,4].”
BackgroundCorrelation between telomerase and mTOR pathway in cancer stem cells
Doğan, F., & Avcı, Ç. B. (2017) · Gene · doi:10.1016/j.gene.2017.09.072 · Cited by 64
TOE1 acts as a 3′ exonuclease for telomerase RNA and regulates telomere maintenance
Deng, T., Huang, Y. Y., Weng, K., Song, L., Li, Y., Shi, G. W., Chen, Y., Huang, J., Liu, D., Ma, W., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky1019 · Cited by 65
Telomerase reverse transcriptase mRNA expression and telomerase activity in hepatocellular carcinoma
Nagao, K., Tomimatsu, M., Endo, H., Hisatomi, H., & Hikiji, K. (1999) · Journal of Gastroenterology · doi:10.1007/s005350050220 · Cited by 63
Concise Review: Telomere Biology in Normal and Leukemic Hematopoietic Stem Cells
Drummond, M. W., Balabanov, S., Holyoake, T. L., & Brümmendorf, T. H. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0057 · Cited by 64
Kim, H. R., Christensen, R. E., Park, N. H., Sapp, P., Kang, M., & Park, N. H. (2001) · PubMed · Cited by 65
Telomerase activation in cervical cancer.
Anderson, S., Shera, K. A., Ihle, J., Billman, L., Goff, B. A., Greer, B. E., Tamimi, H. K., McDougall, J. K., & Klingelhutz, A. J. (1997) · Europe PMC (PubMed Central) · Cited by 67
Association of Nucleoside Diphosphate Kinase nm23-H2 with Human Telomeres
Nosaka, K., Kawahara, M., Masuda, M., Satomi, Y., & Nishino, H. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.8097 · Cited by 60
Crisis intervention: The role of telomerase
Lustig, A. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3339 · Cited by 69
Frink, R. E., Peyton, M., Schiller, J. H., Gazdar, A. F., Shay, J. W., & Minna, J. D. (2016) · Oncotarget · doi:10.18632/oncotarget.9335 · Cited by 68
“hTR is a functional RNA that contains a telomere template component used by the reverse transcriptase to add the appropriate TTAGGG telomeric repeats to human telomeres during each replication cycle to counterbalance the losses due to the end replication problem [8-10].”
Telomeres in Plants and Humans: Not So Different, Not So Similar
Schrumpfová, P. P., Fojtová, M., & Fajkus, J. (2019) · Cells · doi:10.3390/cells8010058 · Cited by 62
“TR RNA subunit of telomerase [113] TER1, TER2, TER2s Putative RNA subunit of telomerase [56,100]”
Induction of a p95/Nbs1‐mediated S phase checkpoint by telomere 3′ overhang specific DNA
Eller, M. S., Li, G., Firoozabadi, R., Puri, N., & Gilchrest, B. A. (2003) · The FASEB Journal · doi:10.1096/fj.02-0197com · Cited by 60
Vaziri, H., & Benchimol, S. (1999) · Oncogene · doi:10.1038/sj.onc.1203016 · Cited by 68
“Forced expression of hTERT in normal human ®broblasts is su cient to fully reconstitute telomerase activity, since the endogenous RNA template of human telomerase (hTR) is expressed in normal human cells (Feng et al., 1995).”
BackgroundInfluentialPreclinical and clinical strategies for development of telomerase and telomere inhibitors
Sharma, S., Raymond, É., Soda, H., Sun, D., Hilsenbeck, S., Sharma, A., Izbicka, E., Windle, B. E., & Hoff, D. D. V. (1997) · Annals of Oncology · doi:10.1023/a:1008206420505 · Cited by 63
“In view of the evidence that T cell activity, in particular, has a role in clonal expansion of cells that are required for effective immune response [17, 18], telomerase inhibitors have the potential for immunosuppression.”
BackgroundMethodInfluentialFunctional Reconstitution of Human Telomerase Expressed inSaccharomyces cerevisiae
Bachand, F., & Autexier, C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.53.38027 · Cited by 69
Telomerase reverse transcriptase moonlights: Therapeutic targets beyond telomerase
Maida, Y., & Masutomi, K. (2015) · Cancer Science · doi:10.1111/cas.12806 · Cited by 63
In vitro lifespan and senescence mechanisms of human nucleus pulposus chondrocytes
Jeong, S.-W., Lee, J., & Kim, K.-W. (2013) · The Spine Journal · doi:10.1016/j.spinee.2013.06.099 · Cited by 65
Ghattas, M. H., Chuang, L. T., Kappas, A., & Abraham, N. G. (2002) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00097-3 · Cited by 59
Ruiz‐Orera, J., & Albà, M. M. (2019) · NAR Genomics and Bioinformatics · doi:10.1093/nargab/lqz002 · Cited by 59
“Other cases were Malat, Neat1, Meg3, Miat and Lncpint, known to interact with different protein and splicing factors, and TERC that acts as a scaffold for the telomerase complex.”
MethodInfluentialComparison of porcine xenografts and homografts for pulmonary valve replacement in children
Dittrich, S., Alexi-Meskishvili, V. V., Yankah, A. C., Dähnert, I., Meyer, R., Hetzer, R., & Lange, P. (2000) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(00)01532-0 · Cited by 65
Wang, J. C. Y., Warner, J. K., Erdmann, N., Lansdorp, P. M., Harrington, L. A., & Dick, J. E. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504161102 · Cited by 67
Molecular Pathology of Non-Small-Cell Lung Cancer
Breuer, R. H. J., Postmus, P. E., & Smit, E. F. (2005) · Respiration · doi:10.1159/000085376 · Cited by 67
“Several components of human telomerase have been identified including the RNA component, hTR [”
Therapeutic Efficacy of PUMA for Malignant Glioma Cells Regardless of p53 Status
Ito, H., Kanzawa, T., Miyoshi, T., Hirohata, S., Kyo, S., Iwamaru, A., Aoki, H., Kondo, Y., & Kondo, S. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.685 · Cited by 64
“Although hTERT and another subunit, the RNA component (hTR) (Feng et al., 1995), are necessary for telomerase activity, their expression patterns are different (Weinrich et al.”
Campbell, L. J., Fidler, C., Eagleton, H., Peniket, A., Kušec, R., Gal, S., Littlewood, T. J., Wainscoat, J. S., & Boultwood, J. (2006) · Leukemia · doi:10.1038/sj.leu.2404141 · Cited by 61
Telomeres, Cancer, and Aging: Altering the Human Life Span
Banks, D. A. (1997) · JAMA · doi:10.1001/jama.1997.03550160065040 · Cited by 65
Telomerase activity in chronic lymphoproliferative disorders of B‐cell lineage
Trentin, L., Ballon, G., Ometto, L., Perin, A., Basso, U., Chieco‐Bianchi, L., Semenzato, G., & Rossi, A. D. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01620.x · Cited by 63
“…such as germline cells, telomere length is maintained by telomerase, a ribonucleoprotein complex consisting of an RNA template complementary of telomeric repeats (Feng et al, 1995) and associated proteins, including one with telomere-speci®c reverse transcriptase activity (Nakamura et al, 1997).”
BackgroundFORD, L. P., SHAY, J. W., & WRIGHT, W. E. (2001) · RNA · doi:10.1017/s1355838201010159 · Cited by 58
Apigenin decreases cell viability and telomerase activity in human leukemia cell lines
Jayasooriya, R. G. P. T., Kang, S.-H., Kang, C., Choi, Y. H., Moon, D., Hyun, J. W., Chang, W. Y., & Kim, G. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.05.024 · Cited by 57
“Although telomerase is a ribonucleoprotein complex comprised of different components in addition to hTERT such as telomerase RNA (TR) template (Feng et al., 1995), telomerase-associated protein (TEP-1) (Harrington et al.”
BackgroundMolecular regulation of telomerase activity in aging
Nicholls, C., Li, H., Wang, J.-Q., & Liu, J.-P. (2011) · Protein & Cell · doi:10.1007/s13238-011-1093-3 · Cited by 53
“The human telomerase RNA component is 451 nucleotides in length and functions as a template that directs the addition of new telomeric repeats to the 3′ end of telomeres (Feng et al., 1995; Autexier et al., 1996).”
The potential utility of telomere‐related markers for cancer diagnosis
Heaphy, C. M., & Meeker, A. K. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01284.x · Cited by 57
Aubert, G. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-397898-1.00004-9 · Cited by 62
The PTEN regulator DJ‐1 is associated with hTERT expression in clear cell renal cell carcinoma
Sitaram, R. T., Cairney, C. J., Grabowski, P., Keith, W. N., Hallberg, B., Ljungberg, B., & Roos, G. (2009) · International Journal of Cancer · doi:10.1002/ijc.24335 · Cited by 59
A novel oncolytic adenovirus targeting to telomerase activity in tumor cells with potent
Zou, W., Luo, C., Zhang, Z., Liu, J., Gu, J.-F., Pei, Z., Qian, C., & Liu, X. (2004) · Oncogene · doi:10.1038/sj.onc.1207033 · Cited by 64
Measurement of Telomerase Activity in Dog Tumors
Yazawa, M., Okuda, M., Setoguchi, A., Nishimura, R., Sasaki, N., Hasegawa, A., WATARI, & Tsujimoto, H. (1999) · Journal of Veterinary Medical Science · doi:10.1292/jvms.61.1125 · Cited by 59
A Novel Regulator of Telomerase
Rosenberger, S., Thorey, I. S., Werner, S., & Boukamp, P. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610529200 · Cited by 56
Fletcher, T. M., Cathers, B. E., Ravikumar, K. S., Mamiya, B. M., & Kerwin, S. M. (2001) · Bioorganic Chemistry · doi:10.1006/bioo.2000.1194 · Cited by 64
Telomere Attrition in Neurodegenerative Disorders
Levstek, T., Kozjek, E., Dolžan, V., & Trebušak Podkrajšek, K. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00219 · Cited by 52
Identification and functional annotation of long intergenic non-coding RNAs in Brassicaceae
Palos, K. R., Dittrich, A. C. N., Yu, L., Brock, J. R., Railey, C. E., Wu, H.-Y. L., Sokolowska, E., Skirycz, A., Hsu, P. Y., Gregory, B. D., et al. (2022) · The Plant Cell · doi:10.1093/plcell/koac166 · Cited by 58
“for chromosome maintenance (Feng et al., 1995); XIST, a”
Halevy, R. S., Amiel, A., Kidron, D., Liberman, M., Ganor‐Paz, Y., & Biron‐Shental, T. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.08.050 · Cited by 62
Nötzold, L., Frank, L., Gandhi, M., Polycarpou‐Schwarz, M., Groß, M., Gunkel, M., Beil, N., Erfle, H., Harder, N., Rohr, K., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-02357-0 · Cited by 67
Wang, K., Liu, Y., Liu, Y., Jiang, L., Zhang, F., Wei, Y., Zhang, Y., Qi, Z., Wang, K., & Liu, S. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b01882 · Cited by 56
Lan, J. Q., Xiong, Y.-Y., Lin, Y.-X., Wang, B.-C., Gong, L.-L., Hui-sen, X., & 郭广松 (2003) · World Journal of Gastroenterology · doi:10.3748/wjg.v9.i1.54 · Cited by 57
Telomerase Inhibition in Cancer Therapeutics: Molecular-Based Approaches
Publisher, B. S. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706778521887 · Cited by 60
Human Embryonic Stem Cells: Mechanisms to Escape Replicative Senescence?
Zeng, X. (2007) · Stem Cell Reviews and Reports · doi:10.1007/s12015-007-9005-x · Cited by 61
“On the other hand, inhibition of telomerase activity in immortalized cells leads to telomere loss and cell death [32, 33].”
BackgroundLazovich, D., Solomon, C. C., Thomas, D. B., Moe, R. E., & White, E. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990815)86:4<628::aid-cncr11>3.0.co;2-l · Cited by 254
Human telomerase RNA-protein interactions
Bachand, F., Triki, I., & Autexier, C. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.16.3385 · Cited by 56
Moróte, J., de Torres, I. M., Càceres, C., Vallejo, C. T., Schwartz, S., & Reventós, J. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990820)84:4<339::aid-ijc1>3.0.co;2-2 · Cited by 84
Ishii, E., Kimura, N., Kato, K., Sako, M., Nagano, M., Nakagawa, A., Okamura, T., Yamaguchi, H., Kawa, K., & Hara, T. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990401)85:7<1470::aid-cncr7>3.0.co;2-s · Cited by 17
Pavlov, V. V., Willner, I., Dishon, A., & Kotler, M. (2004) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2004.06.020 · Cited by 59
Salhab, M., Jiang, W. G., Newbold, R. F., & Mokbel, K. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9622-8 · Cited by 59
“The genes coding for the RNA subunits of telomerase have been cloned from a wide variety of species [28, 35] and have been shown to be essential for telomerase function in vivo [34, 36–39].”
BackgroundVasconcelos, E. J. R., Nunes, V. S., da Silva, M. S., Segatto, M., Myler, P. J., & Cano, M. I. N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112061 · Cited by 60
“template that specifies the sequence of the telomeric repeats [7,8].”
BackgroundChen, Y., Deng, Z., Jiang, S., Hu, Q., Liu, H., Songyang, Z., Ma, W., Chen, S., & Zhao, Y. B. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku1277 · Cited by 65
“The telomerase ribonucleoprotein complex includes hTERT, the protein catalytic subunit (6); hTR, the catalytic telomerase RNA subunit (7); and dyskerin, a protein that stabilizes hTR (8).”
BackgroundReversibility of irreversible aging
Galkin, F., Zhang, B., Dmitriev, S. E., & Gladyshev, V. N. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2018.11.008 · Cited by 51
Disruption of Telomerase RNA Maturation Kinetics Precipitates Disease
Roake, C. M., Chen, L., Chakravarthy, A. L., Ferrell, J. E., Raffa, G. D., & Artandi, S. E. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.02.033 · Cited by 62
“Unlike nearly all vertebrate snoRNAs and scaRNAs, hTR is expressed from its own RNA PolII-promoter and the mechanism for its transcriptional termination as well as the length of its transcriptional unit remain undefined (Feng et al., 1995).”
The human telomere and its relationship to human disease, therapy, and tissue engineering
Moon, I. (2007) · Frontiers in Bioscience · doi:10.2741/2412 · Cited by 54
“Even if the RNA primer were produced exactly at the extreme 3' end, removal of the primer would result in the loss of 8-10 nucleotides.”
BackgroundInfluentialKotoula, V., Hytiroglou, P., Pyrpasopoulou, A., Saxena, R., Thung, S. N., & Papadimitriou, C. S. (2002) · Liver International · doi:10.1046/j.0106-9543.2001.01594.x · Cited by 60
Regulation of Telomerase Activity in Rat Lung Fibroblasts
Liu, T., Nozaki, Y., & Phan, S. H. (2002) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.26.5.4668 · Cited by 55
“Telomerase is a specific multi-subunit ribonucleoprotein that synthesizes TTAGGG telomere DNA onto chromosomal ends by using its intrinsic RNA component as a template, thereby compensating for telomere loss that normally occurs with each cell division (1, 2 ). Telomerase has been shown to be essential for unlimited ce…”
BackgroundHara, H., Yamashita, K., Shinada, J., Yoshimura, H., & Kameya, T. (2001) · Lung Cancer · doi:10.1016/s0169-5002(01)00244-6 · Cited by 60
“Recently, it has been proven that telomerase is composed of a template RNA (hTR) [9], and proteins (TP1 and hTERT) [10,11].”
BackgroundLincz, L. F., Mudge, L.-M., Scorgie, F. E., Sakoff, J. A., Hamilton, C. S., & Seldon, M. (2008) · Neoplasia · doi:10.1593/neo.08644 · Cited by 63
“Telomerase is made up of two essential components: a constitutively expressed human telomerase RNA (hTR), which acts as a transcription template [9,10], and a catalytic human telomerase reverse transcriptase (hTERT), whose expression controls enzymatic activity”
BackgroundThe Solo Play of TERT Promoter Mutations
Hafezi, F., & Perez-Bercoff, D. (2020) · Cells · doi:10.3390/cells9030749 · Cited by 60
Yanada, S., Ochi, M., Kojima, K., Sharman, P., Yasunaga, Y., & Hiyama, E. (2006) · Cell Proliferation · doi:10.1111/j.1365-2184.2006.00397.x · Cited by 59
Imanishi, T., Kobayashi, K., Hano, T., & Nishio, I. (2005) · Hypertension Research · doi:10.1291/hypres.28.763 · Cited by 61
“Studies on telomerase regulation in normal somatic cells have focused on expression of the two essential components of telomerase, telomerase RNA template (hTER) (30) and hTERT (31).”
BackgroundIs small cell lung cancer the perfect target for anti-telomerase treatment?
Sarvesvaran, J. (1999) · Carcinogenesis · doi:10.1093/carcin/20.8.1649 · Cited by 54
KIM, J. H., KIM, J. H., Lee, G. E., KIM, S. W., & CHUNG, I. K. (2003) · Biochemical Journal · doi:10.1042/bj20030363 · Cited by 55
Telomerase: Its clinical relevance in the diagnosis of bladder cancer
Müller, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205071 · Cited by 56
“RT±PCR detection of hTR in the diagnosis of carcinoma of the urinary bladder The RNA component of human telomerase (hTR) was ®rst cloned in 1995 by Feng et al. (1995).”
MethodYan, P., Coindre, J., Benhattar, J., Bosman, F. T., & Guillou, L. (1999) · PubMed · Cited by 58
Metadata
- Authors
- Feng, J., Funk, W. D., Wang, S.-S., Weinrich, S. L., Avilion, A. A., Chiu, C.-P., Adams, R. R., Chang, E., Allsopp, R. C., Yu, J., Le, S., West, M. D., Harley, C. B., Andrews, Greider, C. W., & Villeponteau, B.
- Affiliations
- Geron (United States) (US)
- Cold Spring Harbor Laboratory (US)
- ORCID
- Venue
- Science
- Published
- 1995-09
- Volume
- 269
- Issue
- 5228
- Pages
- 1236-1241
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2026856852
- Cited by
- 2,227
- References
- 44
- Citations by year
- 2026: 10 · 2025: 23 · 2024: 20 · 2023: 36 · 2022: 35 · 2021: 33 · 2020: 44 · 2019: 52 · 2018: 55 · 2017: 44 · 2016: 74 · 2015: 54 · 2014: 47 · 2013: 62 · 2012: 61
- FWCI
- 54.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (AG09383)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA and Nucleic Acid Chemistry
- Keywords
- telomerase, hTR, telomeric repeats, antisense RNA, telomere shortening, HeLa cells
- MeSH terms
- Animals, Base Sequence, Cell Division, Cell Line, Cloning, Molecular, DNA Nucleotidylexotransferase, HeLa Cells, Humans, Molecular Sequence Data, RNA, Templates, Genetic, Transfection, Tumor Cells, Cultured, Polymerase Chain Reaction, Oligonucleotides, Antisense, Cell Death
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.